Hand Control 12FR Suction Coagulator with 10 ft cord and holster, Sterile, Disposable, Model Numb...
FDA Device Recall #Z-1151-2014 — Class II — February 27, 2014
Recall Summary
| Recall Number | Z-1151-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 27, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Megadyne Medical Products, Inc. |
| Location | Draper, UT |
| Product Type | Devices |
| Quantity | 494 |
Product Description
Hand Control 12FR Suction Coagulator with 10 ft cord and holster, Sterile, Disposable, Model Number 0043-25, packaged Tyvek¿ polyester peel pouch, 25 pouches per box. This device is intended to conduct monopolar electrosurgical energy from an electrosurgical generator (ESU) to target tissue during ENT and general surgical procedures. It is also a suction apparatus used to remove surgical smoke and fluids from the site. The device is intended for single use; it is not intended to be cleaned or reused.
Reason for Recall
Megadyne Medical Products, Inc. is voluntarily recalling Hand Control 12Fr Suction Coagulator with 10ft cord and 132405 Holster, Sterile, Disposable, Lot 132405 due to the potential for a small number of these suction coagulators to self-activate immediately on connection to the electrosurgical generator and to remain activated until it is disconnected.
Distribution Pattern
USA including FL, MN, LA, NJ, NM, PA, TX and Internationally to Canada.
Lot / Code Information
Catalog Number: 0043-25 Lot Number: 132405 Exp. Date: 07-2018
Other Recalls from Megadyne Medical Products, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2248-2024 | Class I | Brand Name: MEGADYNE" MEGA 2000" Patient Return... | Jun 17, 2024 |
| Z-2249-2024 | Class I | Brand Name: MEGADYNE" MEGA SOFT" Reusable Patie... | Jun 17, 2024 |
| Z-2250-2024 | Class I | Brand Name: MEGADYNE" MEGA SOFT" Dual Reusable ... | Jun 17, 2024 |
| Z-1920-2024 | Class I | MEGADYNE MEGA SOFT Pediatric Patient Return Ele... | May 8, 2024 |
| Z-0599-2024 | Class I | Product Code 0847, MEGADYNE MEGA SOFT Universal... | Dec 8, 2023 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.